(Q46422776)

English

Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer

scientific article published on 10 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

1 reference

based on heuristic

inferred from title

9

object named as

Masaki Mori

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

10

object named as

Yuichiro Doki

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

Yukinori Kurokawa

6

object named as

Yukinori Kurokawa

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

Shuji Takiguchi

8

object named as

Shuji Takiguchi

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

Kiyokazu Nakajima

7

object named as

Kiyokazu Nakajima

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

2

object named as

Hiroshi Miyata

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

Keijiro Sugimura

4

object named as

Keijiro Sugimura

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

author name string

Koji Tanaka

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

Makoto Yamasaki

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

Tsuyoshi Takahashi

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

publication date

10 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

20 Suppl 3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

S607-15

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Circulating microRNAs as stable blood-based markers for cancer detection

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Circulating microRNAs in plasma of patients with gastric cancers

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Preoperative chemotherapy for clinically node-positive patients with squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

A high-throughput method to monitor the expression of microRNA precursors

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Secretory mechanisms and intercellular transfer of microRNAs in living cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Circulating MiR-125b as a marker predicting chemoresistance in breast cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Selective release of microRNA species from normal and malignant mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3093-4

21 January 2018

Identifiers

10.1245/S10434-013-3093-4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

Dimensions Publication ID

0 references

release_hcx4kckmafenflxr5usorujggu

1 reference

https://api.fatcat.wiki/v0/release/hcx4kckmafenflxr5usorujggu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23838916

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46422776&oldid=2207857291"